Nintai Charitable Trust's 1st-Quarter Results

The NCT got off to a great start, but it's far too early for celebrations

Author's Avatar
Apr 12, 2016
Article's Main Image

There is a story about a teacher who – as many do – receives gifts at the end of the year from her students. Traditionally she would guess each child’s offering. The first student was the son of a florist. When he approached with his gift she guessed, “Is it flowers?” The child said, yes, it was. The next child – the daughter of a candy shop owner – arrived with a wrapped box. “Is it candy?” The child was amazed. “Yes, it is”, she said. The last – a son of a liquor store owner – arrived with a box slowly leaking. She tested the liquid coming from the box. “Is it champagne?” No, she was told. She took another dab with her finger and said, “Is it wine?” “No,” said the student, quite gleeful she hadn’t guessed it. “It’s a puppy!”

Overconfidence can provide all of us with most discomfiting lessons. Indeed, smugness is an emotion that can be very expensive to investors in both the short and long term.

I bring this up because the Nintai Charitable Trust’s portfolio has achieved satisfactory returns over the past 12 months after a rather lackadaisical three-year performance. Much like our school teacher, we don’t think we should break out the champagne just yet.

The first quarter saw some dramatic movement, leaving the markets trading at some of their highest levels ever. What bear market? The Standard & Poor's 500 Total Return Index was up by 2.0%, and the Morningstar Total U.S. Equity Index was up 1.1%. The Nintai Charitable Trust Portfolio was up 6.3% net all fees.

Several stocks have driven outperformance year to date. Dolby Labs (DLB, Financial) was up 32%, Fastenal (FAST, Financial) was up 17%, SEI Investments (SEIC, Financial) was up 14%, and Terra Nitrogen (TNH, Financial) was up 16%. Several companies produced some drag during the quarter including Ansys (ANSS, Financial) down 5%, Mastercard (MA, Financial) down 3% and Novo Nordisk (NVO, Financial) down 3%.

The following is the breakdown of annualized returns by one-year, three-year, five-year and 10-year periods and since inception.

02May2017171539.jpg

Changes to the portfolio

As Dr. Paul Price pointed out in a recent article, the markets hit their low on Feb. 11. Since then, the market has acted like a slingshot with the SPY ETF up 11.5% since the low. I will be candid in saying I have absolutely no idea where the markets are headed. What I did know was there were some striking opportunities to pick up some wonderful companies on the Nintai Charitable Trust watch list. These included the following purchases made during the quarter:

  • ARM Holdings (ARMH, Financial) (New buy – Jan. 1: average share price: $41.08).

ARM designs microprocessors, physical IP and related technology and software and sells development tools to enhance the performance and energy efficiency of high-volume embedded applications. ARM’s technology and patents are at the heart of processers used in nearly every mobile device. Its IP is assured through an interlocking set of patents that assure a competitive moat for an extended period of time. The worldwide growth of mobile devices and interconnectivity provides the company with a long runway for profitable growth.

ARM has generated an average ROE of 14%, FCF/revenue of 36% and net margins of 24% over the past five years. Management has generated a return on capital of 26% over the same period. The company currently has $113 million in cash on the balance sheet with no short- or long-term debt. ARM generates roughly $500 million in free cash annually and yields 0.9%.

  • Check Point Software (CHKP, Financial) (New buy – Jan. 8: average share price: $77.21).

Check Point has been known as the leader in unified threat management (UTM) for the past 20 years. It has spent the last several years retooling its offerings to meet the SaaS model as well as new competitors. Its moat is considerable as it is extraordinarily difficult to swap out UTM security for a new vendor.

Check Point has generated an average ROE of 19%, FCF/revenue of 59% and net margins of 44% over the past five years. Management has generated a return on capital of 39% over the same period. The company currently has $258 million in cash on the balance sheet with no short- or long-term debt. Check Point generates roughly $930 million in free cash annually and does not pay a dividend.

  • SEI Investments (SEIC, Financial) (New buy – Jan. 28: average share price: $36.38).

SEI is one of the leaders in investment processing, investment management and investment operations solutions. SEI provides these services for private banks, financial advisers, institutional managers, investment managers and individuals and families.

SEIC has generated an average ROE of 24%, FCF/revenue of 23% and net margins of 24% over the past five years. Management has generated a return on capital of 28% over the same period. The company currently has $680 million in cash on the balance sheet with no short- or long-term debt. SEIC generates roughly $318 million in free cash annually and yields 1.1%.

  • Visa (V, Financial) (New buy – Jan. 6: average share price: $72.88).

Much like our sister holding Mastercard, Visa runs one of a duopoly based closed network credit and debit card network. It currently has roughly 50% of all credit card transactions and 75% of all debit card transactions (along with extraordinary operational numbers). A wide moat indeed. The movement to credit-based economies will provide Visa with a fantastic long-term growth story.

Visa has generated an average ROE of 16%, FCF/revenue of 40% and net margins of 38% over the past five years. Management has generated a return on capital of 42% over the same period. The company currently has $3.5 billion in cash on the balance sheet with no short- or long-term debt. Visa generates roughly $6.2 billion in cash annually and yields 0.7%.

All of these changes have pushed the portfolio P/E to an abnormally high 19.2 that exceeds the Standard & Poor's 500 by roughly 11%. Other measures (as seen in our standard Abacus view) show on aggregate the portfolio has significantly higher returns on capital, equity and assets. In addition, projected earnings growth is estimated to exceed the S&P 500 by roughly 31% and yields roughly 14% more than the index. These numbers will allow the portfolio to outperform the S&P 500 over the long term.

02May2017171539.jpg

Conclusions

At the beginning of 2016, the Nintai Charitable Trust had roughly 7% of all AUM in cash. By the end of the first quarter this number had dropped to roughly 3%. The market swoon that began last summer and reached its nadir in February allowed the trust to acquire shares in four outstanding companies at a significant discount to my estimated intrinsic value. Over the past 12 months turnover in the portfolio reached nearly 75% on an annual basis. We expect a more normal environment of sloth and indolence to prevail with turnover expected to drop to a far more normal 5% to 10% over the next few years.

Nintai Charitable Trust portfolio holdings: March 31

02May2017171540.jpg